PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
12-Dec-2022 GlycoMimetics Announces New Uproleselan Clinical Data in Both Frontline Unfit and Treated Secondary Acute Myeloid Leukemia presented at ASH Annual Meeting Businesswire
12-Dec-2022 Bristol Myers Squibb Announces First Disclosures and New Data at ASH 2022, Demonstrating Commitment to Raising Standards in Treatment Through Broad Multiple Myeloma Portfolio Businesswire
12-Dec-2022 Hemophilia Treatment Market Report 2022-2030: Growth Influencers Include Preference for Prophylactic Treatment, Rise in Diagnosis Rate, Significant Rise in Usage of Recombinant Coagulation Factor - ResearchAndMarkets.com Businesswire
12-Dec-2022 World Healthcare Industry Almanac 2023: Market Research, Statistics, Trends and Leading Companies - ResearchAndMarkets.com Businesswire
12-Dec-2022 Merck Begins Tender Offer to Acquire Imago BioSciences, Inc. Businesswire
12-Dec-2022 The Worldwide Single-use Assemblies Industry is Expected to Reach $39 Billion by 2030 - ResearchAndMarkets.com Businesswire
12-Dec-2022 Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc Businesswire
12-Dec-2022 Biodesix Ranked Top Proteomics Solutions Company by Life Sciences Review Magazine Businesswire
12-Dec-2022 Global Industrial Hemp Market Report 2022: Growing Use of Hemp Seed and Hemp Seed Oil in Food Applications Fuels Sector - ResearchAndMarkets.com Businesswire
12-Dec-2022 Global Chromatography Reagents Market Report 2022: Growing Awareness about the Benefits of Chromatography Reagents - Forecasts to 2027 - ResearchAndMarkets.com Businesswire
12-Dec-2022 Epigenetics Global Market Report 2022: Growing Applications in Non-Oncology Diseases Bolster Sector - ResearchAndMarkets.com Businesswire
12-Dec-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
12-Dec-2022 TheraVet Optimizes Its Commercial Strategy in France With a New Distribution Agreement for Its BIOCERA-VET® Range Businesswire
12-Dec-2022 Cimeio Therapeutics Presents SCIP Platform Proof-of-Concept Data at ASH Businesswire
12-Dec-2022 Genmab Showcases Data From Robust Development Program Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients Across a Broad Range of B-Cell Lymphomas at the 64th Annual ASH Meeting Businesswire
11-Dec-2022 Se aprueba el uso de QDENGA®▼ (vacuna tetravalente contra el dengue, de virus vivo atenuado) de Takeda en la Unión Europea Businesswire
11-Dec-2022 Genentech Presents New and Updated Data for Polivy in Previously Untreated Diffuse Large B-Cell Lymphoma at ASH 2022 Businesswire
11-Dec-2022 MaaT Pharma Presents Promising Detailed Results from Completed Phase 1b Trial with MaaT033 at the 64th ASH Annual Meeting Businesswire
11-Dec-2022 Wugen Presents Data Supporting Clinical Development of WU-NK-101 for Relapsed / Refractory AML at the American Society of Hematology’s (ASH) 64th Annual Meeting Businesswire
11-Dec-2022 Interim Data From Phase III Study Presented at ASH 2022 Show Hemlibra (emicizumab-kxwh) Achieved Meaningful Bleed Control in Infants From Birth Businesswire